Senseonics Holdings, Inc. to Participate in Upcoming Investor ConferencesGlobeNewsWire · 2 days ago
Senseonics Holdings, Inc. Schedules Third Quarter 2026 Earnings Release and Conference Call for November 9, 2026 at 4:30 P.M. Eastern TimeGlobeNewsWire · 3 days ago
Senseonics: Eversense 365 Adoption Has To Earn The ValuationSeeking Alpha · Oct 8, 2026
Bank of America Corp DE Acquires 394,465 Shares of Senseonics Holdings, Inc. Common Stock $SENSDefense World · Oct 1, 2026
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration DealZacks Investment Research · Sep 29, 2026
Beta Bionics Announces Agreement Integrate the iLet® Bionic Pancreas and mint™ with Senseonics' Eversense® 365GlobeNewsWire · Sep 22, 2026Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 6, 2026 | -$0.61 | -$0.63 | Miss |
| May 7, 2026 | -$0.69 | -$0.71 | Miss |
| Mar 2, 2026 | -$0.43 | -$0.46 | Miss |
| Nov 5, 2025 | -$0.33 | -$0.43 | Miss |
| Aug 6, 2025 | -$0.40 | -$0.40 | Beat |
| May 8, 2025 | -$0.40 | -$0.40 | Beat |